Thursday, January 18, 2007 6:06:08 AM ET J.P. Morgan Securities
LONDON, January 18 (newratings.com) - Analysts at JP Morgan maintain their "overweight" rating on Shire plc (ticker: SHP-GBX), while raising their estimates for the company. The target price has been raised from 1200p to 1250p.
In a research note published this morning, the analysts mention that the Lialda sales estimate for 2011 has been raised from $122 million to $407 million. This estimate appears conservative considering Lialda�s potential to gain market share at the expense of the standard of care therapies and to expand the market, the analysts say. The EPS estimates for 2008, 2009, 2010 and 2011 have been raised from $0.96 to $1.03, from $0.99 to $1.13, from $1.13 to $1.31 and from $1.12 to $1.34, respectively.